| Year |
Citation |
Score |
| 2023 |
Leuthardt AS, Boyle CN, Raun K, Lutz TA, John LM, Le Foll C. Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice. European Journal of Pharmacology. 175912. PMID 37454968 DOI: 10.1016/j.ejphar.2023.175912 |
0.618 |
|
| 2022 |
Christoffersen BØ, Sanchez-Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity (Silver Spring, Md.). 30: 841-857. PMID 35333444 DOI: 10.1002/oby.23374 |
0.608 |
|
| 2021 |
Arrigoni S, Le Foll C, Cabak A, Lundh S, Raun K, John LM, Lutz TA. A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice. The European Journal of Neuroscience. PMID 34189795 DOI: 10.1111/ejn.15376 |
0.636 |
|
| 2021 |
John LM, Kruse T, Raun K. Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity Journal of the Endocrine Society. 5: A54-A54. DOI: 10.1210/jendso/bvab048.108 |
0.618 |
|
| 2021 |
Dahl K, John LM, Skyggebjerg RB, Vegge A, Andersen NK, Raun K. AM833, a Long Acting Amylin Analogue Induces Hypocalcemia in Young Rats via a Calcitonin Receptor Mediated Mechanism Journal of the Endocrine Society. 5: A43-A43. DOI: 10.1210/JENDSO/BVAB048.084 |
0.579 |
|
| 2020 |
Keinicke H, Sun G, Mentzel CMJ, Fredholm M, John LM, Andersen B, Raun K, Kjærgaard M. FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation. Endocrine Connections. PMID 32688339 DOI: 10.1530/Ec-20-0152 |
0.602 |
|
| 2020 |
Zakariassen HL, John LM, Lutz TA. Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases. Basic & Clinical Pharmacology & Toxicology. 127: 163-177. PMID 32363722 DOI: 10.1111/bcpt.13427 |
0.339 |
|
| 2020 |
Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nøhr J, et al. Semaglutide lowers body weight in rodents via distributed neural pathways. Jci Insight. 5. PMID 32213703 DOI: 10.1172/Jci.Insight.133429 |
0.596 |
|
| 2020 |
Zakariassen HL, John LM, Lykkesfeldt J, Raun K, Glendorf T, Schaffer L, Lundh S, Secher A, Lutz TA, Le Foll C. Salmon calcitonin distributes into the arcuate nucleus in mice to a subset of NPY neurons. Neuropharmacology. 107987. PMID 32035146 DOI: 10.1016/J.Neuropharm.2020.107987 |
0.57 |
|
| 2017 |
Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjær SB, Wu X, Huang T, Hultman K, Paulsen SJ, Wang J, Bugge A, Frantzen JB, Nørgaard P, Jeppesen JF, ... ... John LM, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nature Medicine. PMID 28846099 DOI: 10.1038/nm.4394 |
0.345 |
|
| 2004 |
Saelim N, John LM, Wu J, Park JS, Bai Y, Camacho P, Lechleiter JD. Nontranscriptional modulation of intracellular Ca2+ signaling by ligand stimulated thyroid hormone receptor. The Journal of Cell Biology. 167: 915-24. PMID 15569710 DOI: 10.1083/Jcb.200409011 |
0.608 |
|
| 2004 |
Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology. 145: 2594-603. PMID 14976145 DOI: 10.1210/En.2003-1671 |
0.63 |
|
| 2002 |
Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, Stewart TA. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology. 143: 1741-7. PMID 11956156 DOI: 10.1210/Endo.143.5.8850 |
0.628 |
|
| 2001 |
John LM, Mosquera-Caro M, Camacho P, Lechleiter JD. Control of IP3-mediated Ca2+ puffs in Xenopus laevis oocytes by the Ca2+-binding protein parvalbumin The Journal of Physiology. 535: 3-16. PMID 11507154 DOI: 10.1111/J.1469-7793.2001.T01-2-00003.X |
0.354 |
|
| 1998 |
John LM, Lechleiter JD, Camacho P. Differential modulation of SERCA2 isoforms by calreticulin. The Journal of Cell Biology. 142: 963-73. PMID 9722609 DOI: 10.1083/Jcb.142.4.963 |
0.6 |
|
| 1998 |
Lechleiter JD, John LM, Camacho P. Ca2+ wave dispersion and spiral wave entrainment in Xenopus laevis oocytes overexpressing Ca2+ ATPases. Biophysical Chemistry. 72: 123-9. PMID 9652090 DOI: 10.1016/S0301-4622(98)00128-8 |
0.593 |
|
| Show low-probability matches. |